Supriya Lifescience bulk deals, insider trading and stake changes
NSE: SUPRIYABSE: 543434Pharmaceuticals & BiotechnologySmall Cap
Last close ₹818.55down ₹17.70 (2.12%)BSE ₹818.90
Share price at the NSE close on 23 Oct 2026. Previous close ₹836.25.
52-week range of traded prices to 23 Oct 2026
₹545.50Low, 24 Mar 2026₹1,085.00High, 1 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹6,588 Cr733rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 13 Aug 2026
- 33.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 May 2026
- 5.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.12%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- 18.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- 21.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,62,92342.0% delivered
Supriya Lifescience insider trading
All 12 disclosures on record. The company's own latest disclosure on record is from Feb 2024.Insider trading, all companies
Feb 2024
- Shivani Satish Wagh73,125sharesReceived · Promoter Group · 26 Feb 2024 · disclosed 27 Feb · Gift · stake 0.04% before, 0.13% after
- Saloni Satish Wagh73,125sharesGave · Promoter Group · 26 Feb 2024 · disclosed 27 Feb · Gift · stake 0.22% before, 0.13% after
Nov 2023
- SALONI SATISH WAGH₹4.10 Cr1,46,250 sharesBought · Promoter And Designated Person · 29 Nov 2023 · disclosed 4 Dec
- ASHA WAMAN WAGH₹4.10 Cr1,46,250 sharesSold or invoked · Promoter · 29 Nov 2023 · disclosed 4 Dec
Mar 2023
- Satish Waman Wagh₹0.25 Cr13,000 sharesBought · Promoters · 31 Mar 2023 · disclosed 3 Apr · stake 67.63% before, 67.64% after
- Satish Waman Wagh₹0.25 Cr14,000 sharesBought · Promoters · 29 Mar 2023 · disclosed 31 Mar · stake 67.61% before, 67.63% after
- SWASTIK INDUSTRIES₹0.20 Cr10,000 sharesBought · Promoter And Designated Person · 3 Mar 2023 · disclosed 16 Mar
- Satish Waman Wagh₹0.16 Cr8,000 sharesBought · Promoters · 3 Mar 2023 · disclosed 6 Mar · stake 67.60% before, 67.61% after
- Satish Waman Wagh₹0.04 Cr2,000 sharesBought · Promoters · 3 Mar 2023 · disclosed 6 Mar · stake 67.61% before, 67.61% after
Feb 2023
- SATISH WAMAN WAGH₹0.20 Cr10,000 sharesBought · Promoter And Designated Person · 28 Feb 2023 · disclosed 16 Mar
- Satish Waman Wagh₹0.16 Cr8,000 sharesBought · Promoters · 28 Feb 2023 · disclosed 1 Mar · stake 67.58% before, 67.59% after
- Satish Waman Wagh₹0.04 Cr2,000 sharesBought · Promoters · 28 Feb 2023 · disclosed 1 Mar · stake 67.59% before, 67.59% after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Supriya Lifescience stake sales and purchases
All 6 disclosures on record.
Feb 2024
- AcquiredShivani Satish Wagh · promoter0.09% of the company73,125 sharesholds 0.13% after26 Feb 2024 · filed under the 2% rule · Inter-se transfer
- SoldSaloni satish wagh · promoter0.09% of the company73,125 sharesholds 0.13% after26 Feb 2024 · filed under the 2% rule · Inter-se transfer
Mar 2023
- AcquiredDr. satish Wagh · promoter0.02% of the company13,000 sharesholds 5,44,41,205 shares after31 Mar 2023 · filed under the 2% rule · Open Market
- AcquiredDR. Satish wagh · promoter0.02% of the company14,000 sharesholds 67.63% after29 Mar 2023 · filed under the 2% rule · Open Market
- AcquiredDr. Satish Wagh · promoter0.01% of the company10,000 sharesholds 67.61% after3 Mar 2023 · filed under the 2% rule · Open Market
Feb 2023
- AcquiredDr. Satish Wagh · promoter0.01% of the company10,000 sharesholds 67.59% after28 Feb 2023 · filed under the 2% rule · Open Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Supriya Lifescience bulk deals
None in the last 12 months, since 23 Oct 2025.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Friday 22 Nov 20241 firm · ₹46 Cr bought · ₹46 Cr soldNet sold ₹0.01 Cr
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 5,85,068 at ₹784.79Sold 5,85,068 at ₹785.020.73% of the companyNet nil₹46 Cr bought
Monday 12 Aug 20241 firm · ₹32 Cr bought · ₹32 Cr soldNet nil
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 6,58,285 at ₹488.59Sold 6,58,285 at ₹488.610.82% of the companyNet nil₹32 Cr bought
Thursday 8 Feb 20241 firm · ₹21 Cr bought · ₹21 Cr soldNet sold ₹69,057
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 6,27,793 at ₹342.21Sold 6,27,793 at ₹342.320.78% of the companyNet nil₹21 Cr bought
Tuesday 26 Dec 20231 firm · ₹14 Cr bought · ₹14 Cr soldNet sold ₹63,933
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 4,56,665 at ₹312.26Sold 4,56,665 at ₹312.400.57% of the companyNet nil₹14 Cr bought
Friday 12 May 20231 firm · ₹10 Cr bought · ₹10 Cr soldNet nil
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 4,03,147 at ₹248.38Sold 4,03,147 at ₹248.480.50% of the companyNet nil₹10 Cr bought
Monday 27 Mar 20231 firm · ₹0 bought · ₹9.69 Cr soldNet sold ₹9.69 Cr
- SoldDOVETAIL INDIA FUND CLASS 6 SHARESSold 5,47,398 at ₹177.080.68% of the company₹9.69 Cr
Monday 24 Jan 20221 firm · ₹22 Cr bought · ₹22 Cr soldNet sold ₹0.02 Cr
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 4,87,816 at ₹460.03Sold 4,87,816 at ₹460.520.61% of the companyNet nil₹22 Cr bought
Friday 21 Jan 20221 firm · ₹29 Cr bought · ₹29 Cr soldNet bought ₹0.03 Cr
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 5,42,220 at ₹526.90Sold 5,42,220 at ₹526.430.67% of the companyNet nil₹29 Cr bought
Tuesday 18 Jan 20221 firm · ₹52 Cr bought · ₹52 Cr soldNet sold ₹0.05 Cr
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 9,14,497 at ₹572.78Sold 9,14,497 at ₹573.291.14% of the companyNet nil₹52 Cr bought
Thursday 30 Dec 20212 firms · ₹85 Cr bought · ₹85 Cr soldNet sold ₹0.06 Cr
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 9,84,322 at ₹499.96Sold 9,84,322 at ₹500.451.22% of the companyNet nil₹49 Cr bought
- Both waysVAIBHAV STOCK AND DERIVATIVES BROKING PRIVATE LIMITEDBought 7,11,595 at ₹503.76Sold 7,11,595 at ₹503.950.88% of the companyNet nil₹36 Cr bought
Wednesday 29 Dec 20213 firms · ₹70 Cr bought · ₹68 Cr soldNet bought ₹2.15 Cr
- Both waysSTOCK VERTEX VENTURESBought 7,36,536 at ₹463.78Sold 6,36,532 at ₹467.020.92% of the companyNet +1,00,004 shares₹34 Cr bought
- Both waysALPHA LEON ENTERPRISES LLPBought 3,75,507 at ₹465.32Sold 4,24,075 at ₹465.690.53% of the companyNet −48,568 shares₹17 Cr bought
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 4,43,703 at ₹420.13Sold 4,43,703 at ₹420.250.55% of the companyNet nil₹19 Cr bought
Tuesday 28 Dec 20214 firms · ₹72 Cr bought · ₹74 Cr soldNet sold ₹2.07 Cr
- Both waysDIPAN MEHTA COMMODITIES PRIVATE LIMITEDBought 4,06,777 at ₹398.95Sold 4,57,437 at ₹399.42Net −50,660 shares₹16 Cr bought
- Both waysMUSIGMA SECURITIESBought 4,09,139 at ₹398.56Sold 4,09,139 at ₹398.89Net nil₹16 Cr bought
- Both waysVAIBHAV STOCK AND DERIVATIVES BROKING PRIVATE LIMITEDBought 5,48,933 at ₹398.24Sold 5,48,933 at ₹398.37Net nil₹22 Cr bought
- Both waysNK SECURITIES RESEARCH PRIVATE LIMITEDBought 4,38,310 at ₹399.09Sold 4,38,310 at ₹399.24Net nil₹17 Cr bought
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 35 deals on record since listing on 28 Dec 2021.